McGarry, Andrew
Cooper Medical School of Rowan University
2 papers on CoChatORCID 0009-0009-2819-6029
Most cited papers
- Verified
Safety, tolerability, and efficacy of NLY01 in early untreated Parkinson's disease: a randomised, double-blind, placebo-controlled trial
McGarry, A., Rosanbalm, S., Leinonen, M., Olanow, C. W., To, D., Bell, A., Lee, D., Chang, J., Dubow, J., Dhall, R., et al. (2024) · The Lancet Neurology
Parkinson's Disease Mechanisms and TreatmentsNeuroinflammation and Neurodegeneration Mechanisms
Cited by 153
- Verified
Risk factors for suicidality in Huntington disease: An analysis of the 2CARE clinical trial
McGarry, A., McDermott, M. P., Kieburtz, K., Fung, W. L. A., McCusker, E., Peng, J., de Blieck, E. A., Cudkowicz, M., & for the Huntington Study Group 2CARE Investigators and Coordinators (2019) · Neurology
Genetic Neurodegenerative DiseasesSuicide and Self-Harm Studies
Cited by 24
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free